PHB1 and amyotrophic lateral sclerosis: Additionally, broader studies in genetically diverse patient cohorts will be essential to define the prevalence and clinical relevance of SLP2/PHB aggregation and to explore its utility as a biomarker for precision medicine approaches in ALS.